Results 181 to 190 of about 12,722 (192)

Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension

Hypertension, 2017
Kazuomi Kario
exaly  

Occurrence and fate of the angiotensin II receptor antagonist transformation product valsartan acid in the water cycle – A comparative study with selected β-blockers and the persistent anthropogenic wastewater indicators carbamazepine and acesulfame

Water Research, 2013
Karsten Nödler, Olav Hillebrand, Tobias Licha   +2 more
exaly  

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

New England Journal of Medicine, 2003
John J V Mcmurray, Eric J Velazquez, Aldo P Maggioni   +2 more
exaly  

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF

Journal of the American College of Cardiology, 2019
Michael R Zile, Brian Lee Claggett, Milton Packer   +2 more
exaly  

Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study

European Journal of Heart Failure, 2019
Hélène Nougué, Théo Pezel, Mattia Arrigo   +2 more
exaly  

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study

Lancet, The, 2014
Michael A Weber, Jan Basile
exaly  

The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction

Cardiovascular Therapeutics, 2018
Pieter Martens, Wilfried Mullens
exaly  

B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan

Journal of the American College of Cardiology, 2019
Peder Langeland Myhre, Muthiah Vaduganathan, Brian Lee Claggett   +2 more
exaly  

Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts

Circulation: Heart Failure, 2019
Eric M Small
exaly  

Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus

Circulation, 2002
exaly